期刊
PHARMACOLOGICAL RESEARCH
卷 157, 期 -, 页码 -出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2020.104827
关键词
Tetrahydrobiopterin; Energy metabolism; Mitochondria; Cardiovascular diseases
资金
- National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [NRF-2010-0020224, NRF2018R1A2A3074998, NRF-2018R1D1A1A09081767]
- Inje University
- National Research Foundation of Korea (NRF) - Korea government (Ministry of Education) [NRF-2010-0020224, NRF2018R1A2A3074998, NRF-2018R1D1A1A09081767]
Tetrahydrobiopterin (BH4) is an endogenous cofactor for various enzymatic conversions of essential biomole-cules including nitric oxide, tyrosine, dopamine, serotonin and phenylalanine. Depending on the physiological functions of these molecules, BH4 plays multiple roles in the cardiovascular, immune, nervous and endocrine systems. A deficiency of BH4 or an imbalance of the redox state of biopterin has been implicated in various cardiovascular and metabolic diseases. Therefore, supplementation with BH4 is considered as a therapeutic option for these diseases. In addition to the classical nitric oxide synthase (NOS)-dependent role of BH4, recent studies proposed novel NOS-independent roles of BH4 in health and disease conditions. This article reviews the updated role of BH4 in mitochondrial regulation, energy metabolism and cardiovascular and metabolic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据